public-company · medical-implant · neurostimulation
Abbott
At a glance
- Legal name
- Abbott Laboratories
- Aliases
- Abbott Neuromodulation, St. Jude Medical (legacy)
- Type
- public-company
- Focus areas
- medical-implant, neurostimulation, neuromodulation, therapeutic, clinical-grade
- Founded
- Defunct
- —
- Spinout of
- —
- HQ city
- Abbott Park
- HQ country
- US
- Employees
- 115000 (as of 2025-12-31)
- Flagship device
- abbott-infinity-dbs
- Product lines
- —
- In-house manufacturing
- Yes
- Open source
- No
- GitHub org
- —
- Website
- abbott.com
- Blog
- —
- Support
- —
Devices
People
Founders
Wallace Calvin Abbott
Founder · departed
Current leadership
Robert B. Ford
Chairman & CEO
Milestones
Abbott Alkaloidal Company founded by Wallace C. Abbott
St. Jude Infinity DBS receives FDA approval (P140009)
First directional DBS approved in the US.
Abbott completes $25B acquisition of St. Jude Medical
Infinity DBS receives MR-conditional labeling (P140009/S039)
Reputation
Inherited a strong neuromodulation portfolio via St. Jude Medical. Differentiated by Apple-device-based patient/clinician interfaces.